Investment Trusts

HBM Healthcare Investments AG

HBMN:SWX

HBM Healthcare Investments AG

Actions
  • Price (CHF)200.00
  • Today's Change3.00 / 1.52%
  • Shares traded2.27k
  • 1 Year change-1.48%
  • Beta1.0301
Data delayed at least 15 minutes, as of Jul 29 2024 16:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

HBM Healthcare Investments AG is a Switzerland-based venture capital company investing in emerging companies, mainly from the biotechnology and human medicine, diagnostics, as well as medical technology sectors. The Company focuses on unlisted companies, with two-thirds of assets being invested in private companies that offer high value-creation potential. As a holding company, it is involved in the acquisition, disposal and management of a diversified portfolio, as well as in financing and supporting the portfolio firms as a key partner. It focuses on companies with products either at an advanced stage of development or already available on the market. The primary investment areas are Western Europe and the United States. The Company's portfolio includes approximately 25 companies. As of March 31, 2012, the Company had six wholly owned subsidiaries, including three subsidiaries on Cayman Islands, two Barbados-based subsidiaries and a subsidiary in the United States.

  • Revenue in CHF (TTM)59.13m
  • Net income in CHF35.33m
  • Incorporated2001
  • Employees--
More ▼

Profile

Management group(s)HBM Partners Cayman Ltd
AIC sector--
ISINCH0012627250
Launch date14 Feb 2008
Share typeOrdinary Share
StructureInvestment Trust
Base currencyCHF

Objective

HBM Healthcare Investments’ objective is to generate long-term capital gains with investments in private and public companies in the human medicine, biotechnology, medical technology and diagnostics sectors, and related areas. Within its target sector, HBM Healthcare Investments invests predominantly in later-stage private companies which are attractively valued and have a convincing business model, including their product pipeline, technology and management. Investments are made worldwide, primarily in Europe, Asia and North America.

Managed by

Andreas Wicki, Erwin Troxler

Management & contract fees

Management fee (paid quarterly): 0.75% of Company assets plus 0.75% of the Company's market capitalisation. Performance fee (paid annually): 15% on increase in value above the high water mark.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Alpha Group International PLC125.66m101.07m1.24bn443.0012.604.9711.449.862.032.032.535.150.3315--29.42249,304.7026.6517.2442.0729.83----80.4048.46----0.092310.8712.3236.30130.0464.4295.9219.74
Immo Helvetic45.80m34.44m1.24bn--25.621.35--27.128.088.0810.74153.620.0499------3.753.324.223.4476.2975.1175.2165.37--11.040.254090.2513.839.8333.0314.75--1.27
Vietnam Enterprise Investments Limited176.65m142.27m1.26bn0.009.400.8461--7.150.60660.60660.75916.740.1179--56.52--9.494.939.564.9797.0295.9580.5471.92--188.750.000.00122.79--117.43------
Edinburgh Investment Trust PLC160.60m149.85m1.31bn0.009.221.03--8.160.83430.83430.88397.490.1118--14.20--10.444.2310.484.3294.3882.2693.3179.36----0.095688.17157.4320.58211.7828.59---0.8722
Law Debenture Corporation plc151.74m85.51m1.36bn299.0015.741.3915.408.930.57690.57691.036.510.129--4.68446,020.107.275.607.515.7893.8192.7156.3553.61--12.730.165766.49494.99--187.04--38.8211.11
Herald Investment Trust plc233.21m217.18m1.36bn0.006.450.8937--5.823.423.423.6424.730.158--74.71--14.718.4214.748.4393.8989.8793.1388.79----0.000.00115.89--111.87------
Financiere Moncey SA0.0012.92m1.37bn--105.980.7938----73.6073.600.009,826.410.00------0.76420.75970.77380.7688--------49.94--0.0042.98----41.7018.64--4.94
JPmorgan Emerging Markets Inv Trust PLC48.37m25.78m1.37bn0.0054.500.9221--28.340.020.020.03691.180.0311--15.47--1.664.461.664.4677.4485.7153.3178.43----0.009923.22106.57-30.0499.34----5.71
HBM Healthcare Investments AG59.13m35.33m1.37bn--37.140.7815--23.195.305.308.56252.070.0316--804.54--1.897.521.927.6262.3072.8759.7469.94----0.054643.60119.73-38.6199.26----0.00
flatexDEGIRO AG374.99m68.96m1.38bn1.29k20.052.1413.463.690.65350.65353.556.120.0905279.3116.68304,071.601.662.009.4611.2685.7782.5918.3918.301.068.440.84661.50-3.9925.58-32.2532.686.65--
Hipgnosis Songs Fund Ltd131.97m-117.84m1.40bn39.00--1.19--10.60-0.0856-0.08530.09590.85690.0707--1.282,973,937.00-6.32---6.52--82.29---89.29-----3.350.3105---11.40---361.03------
Ashmore Group plc213.00m112.41m1.41bn310.0012.041.4311.736.610.14430.14430.27351.220.1892--2.55603,870.9010.3514.9511.4517.63----54.7055.69----0.005676.82-23.14-7.62-5.88-11.2614.870.2985
Sequoia Economic Infrastrctr Incm Fd Ltd149.91m125.64m1.48bn0.0012.370.8702--9.850.0660.0660.07850.93770.0783------6.563.436.643.5686.9277.5683.8173.14----0.00183.351,089.409.49715.239.81--2.94
Anima Holding SpA1.05bn164.66m1.49bn375.009.531.097.071.420.51130.51133.274.470.4463--172.492,925,664.007.006.989.097.9238.3036.0715.6715.60----0.302651.901.14-0.76423.244.05-62.258.67
Data as of Jul 29 2024. Currency figures normalised to HBM Healthcare Investments AG's reporting currency: Swiss Franc CHF
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.